Get started
Author

B. N. ROGERS

Observed names: B N Rogers, B Rogers
OpenAlex ID: A5111662756
P306 MORF-057, an oral selective α4β7 integrin inhibitor for Inflammatory Bowel Disease, leads to specific target engagement in a single and multiple ascending dose study in healthy subjects
2021 · A Ray, D Cui, et al. · Journal of Crohn s and Colitis · 5
PDF
P1002 Changes in circulating lymphocyte subsets and CCR9 transcripts as mechanistic biomarkers of the small molecule α4β7 inhibitor MORF-057 in patients with Ulcerative Colitis
2025 · A Hussain, P Singhal, et al. · Journal of Crohn s and Colitis · 2
DOP50 Oral α4β7 integrin inhibitor MORF-057 demonstrates exposure driven biomarker response in non-human primates
2022 · J Wong, D Lee, et al. · Journal of Crohn s and Colitis
P037 Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor
2021 · J Jones, D Lee, et al. · Journal of Crohn s and Colitis
DOP64 Discovery of highly selective small-molecule oral inhibitors of integrin α4β7 for the treatment of inflammatory bowel diseases
2020 · J WONG, M Bursavich, et al. · Journal of Crohn s and Colitis
ChemInform Abstract: Synthesis and Biological Evaluation of Non‐Polyene Analogues of Amphotericin B.
1998 · B. N. ROGERS, M. E. SELSTED, et al. · ChemInform
ChemInform Abstract: Configurational Assignment of Polyene Macrolide Antibiotics Using the [13C]Acetonide Analysis
1998 · S. D. RYCHNOVSKY, B. N. ROGERS, et al. · ChemInform
ChemInform Abstract: Stereocontrolled Synthesis of the Tetracyclic Core of the Bisguanidine Alkaloids Palau′amine and Styloguanidine.
1997 · L. E. OVERMAN, B. N. ROGERS, et al. · ChemInform
Tc-99m HMPAO IN ETHANOL: A POTENTIAL NEW FORMULATION FOR RADIOLABELLING POLYMORPHONUCLEAR LEUKOCYTES
1991 · G J Morrissey, B Rogers, et al. · Clinical Nuclear Medicine
Works count: 9
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type